Concepedia

M. O’Brien

MO

2

Publications

37

Citations

2

H-Index

2005

Active since

M. O’Brien is an author specializing in cancer therapeutics, lung cancer, and oncology.

Top concepts

HealthMedicineOncologyLung CancerCancer TherapyRadiation OncologyRadiologyClinical Trials

Publications per year

2005–2005

2

Publications

2

O-082 A randomized phase III trial comparing ionafarnib/carboplatin/paclitaxel versus carboplatin/paclitaxel (CP) in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)

George R. Blumenschein, Carrianne Ludwig, Glyn Thomas et al. · Lung Cancer · 2005 · 24 citations

Ionafarnib/carboplatin/paclitaxel Versus Carboplatin/paclitaxel, Medicine, Metronomic Therapy +8

O-104 XYOTAXT™ vs. gemcitabine or vinorelbine for the treatment of performance status (PS) 2 patients with chemotherapy-naïve advanced non-small cell lung cancer (NSCLC): The STELLAR 4 Phase III study

M. O’Brien, Alan Sandler, Alexander Y. Popovich et al. · Lung Cancer · 2005 · 13 citations

O-104 Xyotaxt™, Medicine, Metronomic Therapy +9

Rows per page

1–2 of 2